Literature DB >> 20686199

The biology of tryptophan depletion and mood disorders.

Lilach Toker1, Shirly Amar, Yuly Bersudsky, Jonathan Benjamin, Ehud Klein.   

Abstract

The involvement of the serotonergic system in the pathophysiology and treatment of affective disorders has been strongly implicated. The tryptophan depletion paradigm is widely used to study the effect of lowering serotonin levels. However, the effects observed in such studies are inconsistent and sometimes contradictory. The present review summarizes and discusses these discrepancies, emphasizing the importance of methodological details such as acute versus chronic tryptophan depletion, patients diagnosis and disease state: euthymic versus acute phase and previous drug treatment. Acute tryptophan depletion as a predictive test for personalized antidepressant treatment is suggested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686199

Source DB:  PubMed          Journal:  Isr J Psychiatry Relat Sci        ISSN: 0333-7308            Impact factor:   0.481


  14 in total

1.  Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains.

Authors:  Wynne Q Zhang; Corey M Smolik; Priscilla A Barba-Escobedo; Monica Gamez; Jesus J Sanchez; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

2.  Tryptophan-enriched cereal intake improves nocturnal sleep, melatonin, serotonin, and total antioxidant capacity levels and mood in elderly humans.

Authors:  R Bravo; S Matito; J Cubero; S D Paredes; L Franco; M Rivero; A B Rodríguez; C Barriga
Journal:  Age (Dordr)       Date:  2012-05-24

Review 3.  Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-03-14       Impact factor: 3.575

4.  IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; George Anderson; André F Carvalho; Sebastien Duleu; Michel Geffard; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-04-01       Impact factor: 5.590

5.  Nod-like receptors are critical for gut-brain axis signalling in mice.

Authors:  Matteo M Pusceddu; Mariana Barboza; Ciara E Keogh; Melinda Schneider; Patricia Stokes; Jessica A Sladek; Hyun Jung D Kim; Cristina Torres-Fuentes; Lily R Goldfild; Shane E Gillis; Ingrid Brust-Mascher; Gonzalo Rabasa; Kyle A Wong; Carlito Lebrilla; Mariana X Byndloss; Charles Maisonneuve; Andreas J Bäumler; Dana J Philpott; Richard L Ferrero; Kim E Barrett; Colin Reardon; Mélanie G Gareau
Journal:  J Physiol       Date:  2019-11-27       Impact factor: 5.182

Review 6.  Dietary and botanical anxiolytics.

Authors:  Elham Alramadhan; Mirna S Hanna; Mena S Hanna; Todd A Goldstein; Samantha M Avila; Benjamin S Weeks
Journal:  Med Sci Monit       Date:  2012-04

7.  Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice.

Authors:  Ashwini V Karve; Sagar S Jagtiani; Kunal A Chitnis
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

8.  Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors.

Authors:  Janelle H P van Wel; Kim P C Kuypers; Eef L Theunissen; Wendy M Bosker; Katja Bakker; Johannes G Ramaekers
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

9.  Biomarkers and the future of treatment for depression.

Authors:  Marisa Toups; Madhukar H Trivedi
Journal:  Cerebrum       Date:  2012-05-30

Review 10.  Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.

Authors:  Michael Maes; Michael Berk; Lisa Goehler; Cai Song; George Anderson; Piotr Gałecki; Brian Leonard
Journal:  BMC Med       Date:  2012-06-29       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.